Literature DB >> 15974560

A "one-day survey": as a reliable estimation of the potential recruitment for proton- and carbon- ion therapy in France.

Marie Hélène Baron1, Pascal Pommier, Véronique Favrel, Gilles Truc, Jacques Balosso, Joel Rochat.   

Abstract

To estimate the real figure of the potential patient recruitment for hadrontherapy we carried out a survey directly in 5 radiation therapy departments of the East of France as a "one-day survey". The results presented account for 77 cases of potential indications among 532 evaluated medical records.

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15974560     DOI： 10.1016/s0167-8140(04)80005-7

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN： 0167-8140            Impact factor:   6.280


  5 in total

1.  ENLIGHT and other EU-funded projects in hadron therapy.

Authors:  M Dosanjh; B Jones; R Mayer; R Meyer
Journal:  Br J Radiol       Date:  2010-10       Impact factor: 3.039

2.  Patients With Cancer in the Countries of South-East Europe (the Balkans) Region and Prospective of the Particle Therapy Center: South-East European International Institute for Sustainable Technologies (SEEIIST).

Authors:  Mimoza M Ristova; Vesna Gershan; Herwig Schopper; Ugo Amaldi; Manjit Dosanjh
Journal:  Adv Radiat Oncol       Date:  2021-08-09

3.  Proton therapy needs further technological development to fulfill the promise of becoming a superior treatment modality (compared to photon therapy).

Authors:  Daniel E Hyer; Xuanfeng Ding; Yi Rong
Journal:  J Appl Clin Med Phys       Date:  2021-11-03       Impact factor: 2.102

4.  Epidemiological study of the incidence of cancers eligible for proton or carbon ions therapy: methodology and results of recruitment estimation.

Authors:  Stéphanie Patin; Pascal Pommier; Hu Yi; Marie Hélène Baron; Jacques Balosso
Journal:  J Cancer Epidemiol       Date:  2013-06-20

5.  A Preliminary Study on the Estimation of the Number of Cancer Patients Eligible for Hadron Therapy in Iran and Fars Province.

Authors:  Mohammad Amin Hosseini; Mohammad Mohamadianpanah; Mohammad Zare-Bandeamiri; Mohammad Amin Mosleh-Shirazi
Journal:  Iran J Med Sci       Date:  2018-05
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.